CFHR1 and idiopathic pulmonary fibrosis: Therefore, discontinued PFD treatment or RGS2 inhibition can activate the thrombin-induced differentiation and proliferation of HFL1 cells, indicating that HFL1 cells are a key component of IPF [110].